BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
3 results:

  • 1. Does Utilizing iris, a Segmented Three-dimensional Model, Increase Surgical Precision During Robotic Partial Nephrectomy?
    Iarajuli T; Caviasco C; Corse T; Kim K; Nguyen J; De La Rosa RS; Gelman S; Spagnuolo N; Sidoti H; Miller M; Stifelman M
    J Urol; 2023 Jul; 210(1):171-178. PubMed ID: 37027312
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
    Shiff B; Breau RH; Patel P; Mallick R; Tanguay S; So A; Lavallée L; Moore R; Rendon R; Kapoor A; Pouliot F; Finelli A; Bhindi B; Lattouf JB; Basappa N; Wood L; Heng D; Bjarnason G; Drachenberg D
    J Urol; 2021 Jan; 205(1):78-85. PubMed ID: 32614274
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
    Joseph RW; Kapur P; Serie DJ; Eckel-Passow JE; Parasramka M; Ho T; Cheville JC; Frenkel E; Rakheja D; Brugarolas J; Parker A
    Cancer; 2014 Apr; 120(7):1059-67. PubMed ID: 24382589
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.